November 7, 2024
The rollercoaster ride continues
As someone who’s been covering Tandem since the beginning yesterday’s earnings announcement came as no surprise. It’s a huge understatement to say that Tandem has been a thrilling rollercoaster ride. Frankly no other company in the insulin pump space better represents how this space works. As we have stated many times success in the space is a combination of factors not the least of which being watching the competition screw up.
Tandem has not just come back once but now twice from the jaws of death. The Mobi has surpassed all expectations, the company is now in . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.
